Noven acquires global rights to Daytrana from Shire affiliates

Links shared publicly online about this topic.

  • 833
    total visits

Noven acquires global rights to Daytrana from Shire affiliates

news-medical.net —

Noven Pharmaceuticals, Inc. today announced that it has completed the acquisition of global rights to Daytrana® (methylphenidate transdermal system) from affiliates of Shire plc.

View full resource at news-medical.net

Tags: ADHD Medication, Pharma, Concerta, Metadate CD, Metadate ER, Methylin, Ritalin, Shire

  • Share

Most Recently Shared on October 1, 2010 at 9:10 pm By:

Stroke_News News-Medical.Net

Stroke News: Noven acquires global rights to Daytrana from Shire affiliates: Noven Pharmaceuticals, Inc. today a... http://twurl.nl/7t60g8

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

News-Medical.Net News-Medical.Net

Advertisement